ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP08

Framework for Enhancing Patient-Physician Communication in the Context of Rare Disease

Ida Hakkarinen1 and Kaitlin Quinn 2, 1Vasculitis Patient-Powered Research Network (VPPRN) / Member, Vasculitis Foundation, Greenbelt, Maryland, 2Division of Rheumatology / Department of Medicine / Georgetown University Medical Center, Washington, District of Columbia

Meeting: 2019 ACR/ARP Annual Meeting

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Patient Perspectives Poster Session

Session Type: Poster Session (Sunday)

Session Time: 11:30AM-1:30PM

Background/Purpose: For over two years, I experienced a variety of symptoms including:  joint aches, sinus congestion, shortness of breath and chronic cough. An episode of hemoptysis led to laryngoscopy and a diagnosis of subglottic stenosis. Test results showed a high ANCA titer. Referral to a rheumatologist resulted in a diagnosis in 2012 of Granulomatosis with Polyangiitis (GPA), a rare disease with estimated incidence of 10-12 per million in the U.S. (Banerjee and Grayson, 2017). I’ve been hospitalized twice with relapses and received serial rituximab.

Treatment: To provide a framework for enhancing patient-physician communication, I applied work tools I use regularly:  1) an org chart, 2) a quad chart, and 3) a risk chart. I made my org chart about 6 months after diagnosis, updating it in 2018 to add photos. The chart lists my physicians, their specialties, and their roles in managing my health. I use a quad chart as a briefing tool for clinic visits to list medical history, updates to medications, topics I want to cover, and upcoming appointments. I made a risk chart to assess the likelihood of acquiring Pneumocystis pneumonia given I was having rituximab infusions. I used the chart with my rheumatologist in the shared decision-making process regarding trimethoprim/sulfamethoxazole for prophylaxis.

Maintenance: KQ:  I first met this patient in 2015 during my rheumatology fellowship and became her clinical rheumatologist in 2017. The charts she provides help to inform and enhance our communications and coordination. The org chart provides an overview of other specialists involved in care and the quad chart highlights her main concerns to be discussed at the clinic visit. Additionally, her quad chart always includes a picture of a family member so that we discuss other important events going on in her life. These charts are an easy way to make sure we are addressing the patient’s health needs in an organized and efficient manner.
IH:  Use of these tools has positively impacted communication with my physicians. With my org chart, a new doctor may see at a glance my medical team, as well as their faces. The quad chart provides a systematic way to organize my thoughts prior to a clinic appointment. The risk chart provides an assessment of benefits and risks for a given course of action as an aid to discussion with my physician.
I have a rare disease that all physicians learned about in medical school but most never experience in clinical practice. Consistent briefing tools for my clinic visits enhance the efficiency and effectiveness of the patient-physician interaction.

Quality of Life: I’m grateful my GPA remains quiescent. I appreciate my team of medical professionals who work in partnership with me to monitor and treat this rare, chronic, and potentially life-threatening disease. Shortly after diagnosis, I became a member of the Vasculitis Foundation, a patient advocacy group. In 2014, I joined a natural history study in the Vasculitis Translational Research Program at the National Institutes of Health. My six-word memoir is: “Thanks to research, living with vasculitis.”

Reference:
Shubhasree Banerjee and Peter C. Grayson. Vasculitis around the world: Epidemiologic insights into causality and a need for global partnerships. J Rheumatol 2017;44(2):136-139

Fig. 1


Fig 1 – org chart

Org Chart

Fig. 2


Fig 2 – quad chart

Quad Chart

Fig. 3


Fig 3 – risk chart

Risk Chart


Disclosure: I. Hakkarinen, None; K. Quinn, None.

To cite this abstract in AMA style:

Hakkarinen I, Quinn K. Framework for Enhancing Patient-Physician Communication in the Context of Rare Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/framework-for-enhancing-patient-physician-communication-in-the-context-of-rare-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/framework-for-enhancing-patient-physician-communication-in-the-context-of-rare-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology